Sfoglia per Rivista SEMINARS IN ARTHRITIS AND RHEUMATISM
Avascular bone necrosis: An underestimated complication of systemic sclerosis
2017-01-01 Bruni, Cosimo; Guiducci, Serena; Bellando-Randone, Silvia; Matucci-Cerinic, Marco
Changes in T-cell responses against human herpes virus-8 correlate with the disease course of latrogenic kaposi’s sarcoma in a patient with undifferentiated arthritis
2009-01-01 Barozzi, P; Potenza, L; Riva, G; Vallerini, D; Quadrelli, C; Bosco, R; Morselli, M; Forghieri, F; Volzone, F; Rossi, G; Ferri, C; Bonini, MARIA CHIARA; Ciceri, Fabio; Bordignon, Claudio; Whitby, D; Schulz, Tf; Torelli, G; Luppi, M.
COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients
2020-01-01 Ramirez, G. A.; Gerosa, M.; Beretta, L.; Bellocchi, C.; Argolini, L. M.; Moroni, L.; Della Torre, E.; Artusi, C.; Nicolosi, S.; Caporali, R.; Bozzolo, E. P.; Dagna, L.
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis
2021-01-01 Campochiaro, C.; Tomelleri, A.; Sartorelli, S.; Cavalli, G.; De Luca, G.; Baldissera, E.; Dagna, L.
Drug retention rates of biological agents in adult onset Still's disease
2021-01-01 Campochiaro, C.; Farina, N.; Tomelleri, A.; De Luca, Giacomo.; Baldissera, E.; Cavalli, G.; Dagna, L.
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study
2023-01-01 Tomelleri, A.; Campochiaro, C.; Farina, N.; Mariotti, L.; Baldissera, E.; Grayson, P. C.; Matucci-Cerinic, M.; Dagna, L.
Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab
2015-01-01 Berti, A; Cavalli, G; Campochiaro, C; Guglielmi, B; Baldissera, E; Cappio, S; Sabbadini, Mg; Doglioni, C; Dagna, Lorenzo
Juxta-vertebral lesions in granulomatosis with polyangiitis
2016-01-01 Ramirez, Ga; Della Torre, E; Campochiaro, C; Bozzolo, E; Berti, A; Praderio, L; Dagna, Lorenzo; Sabbadini, M. G.; DELLA TORRE, Emanuel
Prevalence of Fibromyalgia: A Survey in Five European Countries
2010-01-01 Branco, Jc; Bannwarth, B; Failde, I; Abello Carbonell, J; Blotman, F; Spaeth, M; Saraiva, F; Nacci, Francesca; Thomas, E; Caubère, Jp; Le Lay, K; Taieb, C; MATUCCI CERINIC, Marco
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression
2014-01-01 Pieroni, M; De Santis, M; Zizzo, G; Bosello, S; Smaldone, C; Campioni, M; De Luca, G; Laria, A; Meduri, A; Bellocci, F; Bonomo, L; Crea, F; Ferraccioli, G
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis
2016-01-01 Cantini, Fabrizio; Niccoli, Laura; Nannini, Carlotta; Cassarà, Emanuele; Kaloudi, Olga; Giulio Favalli, Ennio; Becciolini, Andrea; Biggioggero, Martina; Benucci, Maurizio; Li Gobbi, Francesca; Grossi, Valentina; Infantino, Maria; Meacci, Francesca; Manfredi, Mariangela; Guiducci, Serena; BELLANDO RANDONE, Silvia; MATUCCI CERINIC, Marco; Foti, Rosario; Di Gangi, Marcella; Mosca, Marta; Tani, Chiara; Palmieri, Fabrizio; Goletti, Delia
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity
2012-01-01 Cappelli, S; Bellando Randone, S; Martinović, D; Tamas, Mm; Pasalić, K; Allanore, Y; Mosca, M; Talarico, R; Opris, D; Kiss, Cg; Tausche, Ak; Cardarelli, S; Riccieri, V; Koneva, O; Cuomo, G; Becker, Mo; Sulli, A; Guiducci, S; Matucci Cerinic, M; Radić, M; Bombardieri, S; Aringer, M; Cozzi, F; Valesini, G; Ananyeva, L; Valentini, G; Riemekasten, G; Cutolo, M; Ionescu, R; Czirják, L; Damjanov, N; Rednic, S
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease
2021-01-01 Della Torre, E.; Lanzillotta, M.; Germano, T.; Mancuso, G.; Ramirez, G. A.; Capurso, G.; Falconi, M.; Dagna, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Avascular bone necrosis: An underestimated complication of systemic sclerosis | 1-gen-2017 | Bruni, Cosimo; Guiducci, Serena; Bellando-Randone, Silvia; Matucci-Cerinic, Marco | |
| Changes in T-cell responses against human herpes virus-8 correlate with the disease course of latrogenic kaposi’s sarcoma in a patient with undifferentiated arthritis | 1-gen-2009 | Barozzi, P; Potenza, L; Riva, G; Vallerini, D; Quadrelli, C; Bosco, R; Morselli, M; Forghieri, F; Volzone, F; Rossi, G; Ferri, C; Bonini, MARIA CHIARA; Ciceri, Fabio; Bordignon, Claudio; Whitby, D; Schulz, Tf; Torelli, G; Luppi, M. | |
| COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients | 1-gen-2020 | Ramirez, G. A.; Gerosa, M.; Beretta, L.; Bellocchi, C.; Argolini, L. M.; Moroni, L.; Della Torre, E.; Artusi, C.; Nicolosi, S.; Caporali, R.; Bozzolo, E. P.; Dagna, L. | |
| Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis | 1-gen-2021 | Campochiaro, C.; Tomelleri, A.; Sartorelli, S.; Cavalli, G.; De Luca, G.; Baldissera, E.; Dagna, L. | |
| Drug retention rates of biological agents in adult onset Still's disease | 1-gen-2021 | Campochiaro, C.; Farina, N.; Tomelleri, A.; De Luca, Giacomo.; Baldissera, E.; Cavalli, G.; Dagna, L. | |
| Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study | 1-gen-2023 | Tomelleri, A.; Campochiaro, C.; Farina, N.; Mariotti, L.; Baldissera, E.; Grayson, P. C.; Matucci-Cerinic, M.; Dagna, L. | |
| Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab | 1-gen-2015 | Berti, A; Cavalli, G; Campochiaro, C; Guglielmi, B; Baldissera, E; Cappio, S; Sabbadini, Mg; Doglioni, C; Dagna, Lorenzo | |
| Juxta-vertebral lesions in granulomatosis with polyangiitis | 1-gen-2016 | Ramirez, Ga; Della Torre, E; Campochiaro, C; Bozzolo, E; Berti, A; Praderio, L; Dagna, Lorenzo; Sabbadini, M. G.; DELLA TORRE, Emanuel | |
| Prevalence of Fibromyalgia: A Survey in Five European Countries | 1-gen-2010 | Branco, Jc; Bannwarth, B; Failde, I; Abello Carbonell, J; Blotman, F; Spaeth, M; Saraiva, F; Nacci, Francesca; Thomas, E; Caubère, Jp; Le Lay, K; Taieb, C; MATUCCI CERINIC, Marco | |
| Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression | 1-gen-2014 | Pieroni, M; De Santis, M; Zizzo, G; Bosello, S; Smaldone, C; Campioni, M; De Luca, G; Laria, A; Meduri, A; Bellocci, F; Bonomo, L; Crea, F; Ferraccioli, G | |
| Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis | 1-gen-2016 | Cantini, Fabrizio; Niccoli, Laura; Nannini, Carlotta; Cassarà, Emanuele; Kaloudi, Olga; Giulio Favalli, Ennio; Becciolini, Andrea; Biggioggero, Martina; Benucci, Maurizio; Li Gobbi, Francesca; Grossi, Valentina; Infantino, Maria; Meacci, Francesca; Manfredi, Mariangela; Guiducci, Serena; BELLANDO RANDONE, Silvia; MATUCCI CERINIC, Marco; Foti, Rosario; Di Gangi, Marcella; Mosca, Marta; Tani, Chiara; Palmieri, Fabrizio; Goletti, Delia | |
| "To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity | 1-gen-2012 | Cappelli, S; Bellando Randone, S; Martinović, D; Tamas, Mm; Pasalić, K; Allanore, Y; Mosca, M; Talarico, R; Opris, D; Kiss, Cg; Tausche, Ak; Cardarelli, S; Riccieri, V; Koneva, O; Cuomo, G; Becker, Mo; Sulli, A; Guiducci, S; Matucci Cerinic, M; Radić, M; Bombardieri, S; Aringer, M; Cozzi, F; Valesini, G; Ananyeva, L; Valentini, G; Riemekasten, G; Cutolo, M; Ionescu, R; Czirják, L; Damjanov, N; Rednic, S | |
| Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease | 1-gen-2021 | Della Torre, E.; Lanzillotta, M.; Germano, T.; Mancuso, G.; Ramirez, G. A.; Capurso, G.; Falconi, M.; Dagna, L. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile